Add BrightSurf on Google Email

Pennington Biomedical Research Center


Pennington Biomedical Research Center recruiting participants for lipedema research study

The Pennington Biomedical Research Center is conducting a clinical trial to better understand lipedema. Participants will undergo comprehensive assessments and imaging techniques to help advance medical knowledge related to chronic disease. Compensation of up to $475 is offered for participation in the three-month study.

SourcePennington Biomedical Research Center·TypeObservational study·DateJun 11, 2024

Pennington Biomedical’s Dr. Steven Heymsfield and colleague publish guidance on energy and macronutrients across the lifespan

A study published in the New England Journal of Medicine provides recommendations for protein, carbohydrates, fat, fiber, and water intake at various stages of life to support overall health. The guidance, developed by Dr. Steven Heymsfield and Dr. Sue Shapses, aims to promote personalized diets with key macronutrients.

SourcePennington Biomedical Research Center·JournalNew England Journal of Medicine·DateApr 17, 2024

Comparative study of type 2 diabetes medications show differences in medication acceptance, quality-of-life, insulin secretion and mortality

A comparative study of four major type 2 diabetes medications reveals differences in medication acceptance, quality of life, insulin secretion, and mortality. The GRADE Study found that younger age and higher blood sugar levels at baseline were associated with poor blood sugar control over time.

SourcePennington Biomedical Research Center·JournalDiabetes Care·DateMar 25, 2024

Pennington Biomedical researchers looking for new ways to improve life span and health during aging

Researchers found that a compound called BAM15 makes mitochondria less efficient at producing energy, extending life span and improving body composition in fruit flies. The study also showed reduced age-related decline in motor activity. Further studies are needed to confirm these findings in humans.

SourcePennington Biomedical Research Center·JournalAging Cell·TypeExperimental study·DateFeb 21, 2024

More than $13M awarded to study childhood obesity interventions in rural and minority communities in Louisiana and Tennessee

Researchers aim to determine optimal duration and intensity of behavioral interventions for childhood obesity among rural and minority children. The five-year study, funded by the Patient-Centered Outcomes Research Institute, will enroll 900 parent-child pairs and compare different 'dosing' combinations of face-to-face intervention time.

Semaglutide delivers 20 percent reduction in major adverse cardiovascular events in patients with obesity but no history of diabetes

A 20% reduction in major adverse cardiovascular events has been observed for patients with obesity but no history of diabetes taking semaglutide. This study marks a significant milestone, demonstrating the cardiovascular benefits of semaglutide beyond its weight loss effects.

SourcePennington Biomedical Research Center·JournalNew England Journal of Medicine·DateNov 13, 2023

Diabetes Magazine Paper of the Month features Pennington Biomedical research demonstrating the link between exercise and improved pancreatic function and insulin secretion

A recent study by Pennington Biomedical Research Center identifies GDF15 as a protein that acts as a cellular signal to enhance insulin secretion. High-intensity exercise training in patients with type 2 diabetes was found to have elevated levels of GDF15, associated with improved glycemic control.

Study shows physical activity prevents, not just delays, cancer recurrence in patients previously treated for colon cancer

Researchers found that physical activity can prevent cancer recurrence in stage III colon cancer patients by lowering the recurrence rate within the first year of treatment. This association persisted for approximately three years after surgery, suggesting a long-term survival benefit.

SourcePennington Biomedical Research Center·JournalBritish Journal of Sports Medicine·TypeRandomized controlled/clinical trial·DateMar 21, 2023

App Boosts Preschoolers’ Motor Skills

A new study published in Pediatrics found that a 12-week app program improved children's motor skills by an average of 15.5 percentage points. The app-based program focused on six motor skills, including hopping, throwing, and jumping, and was shown to be effective in preventing childhood obesity.

SourcePennington Biomedical Research Center·JournalPEDIATRICS·TypeRandomized controlled/clinical trial·DateJun 7, 2022

Custom program helps people living with diabetes control blood sugar, weight

A customized WeightWatchers program has been shown to effectively manage Type 2 diabetes by lowering blood glucose levels and promoting significant weight loss. Participants in the six-month clinical trial experienced improved glycemic control and overall well-being, with clinically meaningful and statistically significant results.

SourcePennington Biomedical Research Center·JournalDiabetes·TypeRandomized controlled/clinical trial·DateJun 4, 2022

Enhancing blood sugar control boosts brain health for people with type 2 diabetes

Controlling blood sugar levels boosts cognitive function, including thinking, learning, and remembering. However, more weight loss and exercise only improve executive function skills, while verbal learning and memory decline. Effective management of type 2 diabetes is crucial to offset its negative effects on brain health.

SourcePennington Biomedical Research Center·JournalThe Journal of Clinical Endocrinology & Metabolism·DateOct 2, 2020